ABUS Arbutus Biopharma Corporation

NASDAQ
$4.77

Arbutus Biopharma Corporation (ABUS) SEC Filings

Everything ABUS has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

2 filings
Date Form Filing
8-K OTHER_EVENT
8-K CAPITAL_RAISE

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.